default author photo

Andreas E. Kulozik

University of Heidelberg

Germany

  • University of Heidelberg

SCHOLARLY PAPERS

1

DOWNLOADS

188

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Betibeglogene Autotemcel Gene Therapy in Patients with Transfusion-Dependent, Severe Genotype β‑Thalassaemia: Results from the HGB-212 (Northstar-3) Study

Number of pages: 44 Posted: 25 Apr 2024
Janet L. Kwiatkowski, Mark C. Walters, Suradej Hongeng, Evangelia Yannaki, Andreas E. Kulozik, Joachim B. Kunz, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, Ge Tao, Shamshad Ali, Himal Takar, Heidi Elliot, Ankit Lodaya, Ji Lee, Richard A. Colvin, Franco Locatelli and Alexis A. Thompson
University of Pennsylvania, UCSF Benioff Children’s Hospital Oakland - Children’s Hospital Oakland Research Institute, Mahidol University - Division of Pediatric Hematology-Oncology, "G. Papanikolaou” General Hospital of Thessaloniki, University of Heidelberg, University of Heidelberg, Hannover Medical School, Great Ormond Street Hospital, Aix-Marseille University - Hôpital de la Timone, University of California, San Francisco (UCSF), Bluebird Bio Inc, Bluebird Bio Inc, Bluebird Bio Inc, Bluebird Bio Inc, Bluebird Bio Inc, Bluebird Bio Inc, Bluebird Bio Inc, Bambino Gesù Children's Hospital - Department of Pediatric Hematology and Oncology and University of Pennsylvania
Downloads 188 (422,345)

Abstract:

Loading...

beta-thalassaemia, gene addition therapy, genetic vectors, lentivirus, transfusion-independence